Pay in installments of $6.98 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 23 - Jul 28
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
GLP 1 RA prescription trends: January 2018 December 2024 Truveta Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP 1 Crisis Pharmacy Times GLP 1 Agonists and Psoriasis: A Potential Novel Therapeutic Approach GLP 1 Energy and Metabolism Booster Capsules by Troomy Troomy Nootropics GLP 1 baby boom is becoming a real conversation As more women stop medications like Ozempic or Mounjaro, cycles may return, ovulation can improve, and unexpected pregnancies are happening more often. Weight loss Shed Dosing schedule for semaglutide GLP 1 drops + tips for success
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.0 ★★★★★
Based on 12 reviews
Sort
Product Reviews
★★★★★ 5
Cute under armor socks
Size: Medium, Color: Black/Assorted
There's no show under armour socks.Are perfect for anybody who likes thinner socks. I loved them, I love the design the colors and the comfort and fit. Hylie recommend to those of you who like thinner socks.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 22, 2024
★★★★★ 4
Well made and perform well, a little constricting
Size: Medium, Color: Black Assortment (6-pairs)
These socks definitely keep most of the moisture away from my feet, even in wet conditions, which is why I bought them. I am diabetic, though, and the recommendation is to wear socks that don't constrict at any point. These have a tight band around the opening that while it is not uncomfortable on, leaves a mark when I take them off. So far it's been ok, but if you have any kind of swelling in your feet or ankles these would probably not be the best. My foot measures size 8 and I wear size 9 Brooks running shoes. The socks fit me just right but based on the size of the opening and the overall length, I wouldn't think they would fit anyone more than a size larger. Overall well made and perform well as you would expect from this brand.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 20, 2018
★★★★★ 5
long lasting!
Size: Medium, Color: Black/Assorted
literally my favorite sock i will buy forever. they just started busting through after 6 years and i wear them a lot
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 13, 2025
★★★★★ 5
Good quality
Size: Medium, Color: Black/Assorted
Comfy and sturdy
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 27, 2025
★★★★★ 5
Favorite socks
Size: Medium, Color: Black/Assorted
These are my go to socks! Love these. Great towards sweat and different weather temperatures. Mostly use for working out and love them. Will be getting more!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 9, 2024
recommand products
Semaglutide vs. Tirzepatide ⚖️ Not sure which option is right for you? Semaglutide offers steady, gradual results by mimicking the GLP-1 hormone, while Tirzepatide uses a dual-action approach for potentially faster weight
28.19
Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT
21.91
Body weight loss with tirzepatide in SURPASS 1‐5.56,73‐76,87 Data are
21.65
tirzepatide indications fda New Medication approved by the FDA for Chronic Weight Management!-covingtoncountyhospital
21.01
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
25.42